Oxolife has established a collaboration with the Energy Balance, Puberty and Reproductive Health Group of the University … [Read more...] about BIOTECH COMPANY OXOLIFE AND UNIVERSITY OF CORDOBA ARE TESTING A NEW DRUG TO IMPROVE FERTILITY IN WOMEN WITH POLYCYSTIC OVARY
OXOLIFE RECEIVES SEAL OF EXCELLENCE FROM THE EUROPEAN COMMISSION
OXOLIFE is celebrating. The European Commission has awarded us with the “Seal of Excellence” for our … [Read more...] about OXOLIFE RECEIVES SEAL OF EXCELLENCE FROM THE EUROPEAN COMMISSION
OXOLIFE, 1 OF THE 10 NEW STARTUPS WITH HIGHEST POTENCIAL
Experts from fields related to emerging companies in the technological, biomedical and industrial environment, have … [Read more...] about OXOLIFE, 1 OF THE 10 NEW STARTUPS WITH HIGHEST POTENCIAL
BIOTECHNOLOGY THAT HELPS WOMEN TO BECOME MOTHER
Oxolife, an emerging biotechnology company, is the first to focus on promoting the implantation of embryo in the … [Read more...] about BIOTECHNOLOGY THAT HELPS WOMEN TO BECOME MOTHER
HAS BEEN SELECTED BY THE EUROPEAN EIT HEALTH HEADSTART 2020 FUNDING PROGRAM
96 start-ups will receive mentoring and financial support to accelerate the development of promising health solutions. … [Read more...] about HAS BEEN SELECTED BY THE EUROPEAN EIT HEALTH HEADSTART 2020 FUNDING PROGRAM
FINANCIAL TIMES: “OXOLIFE IS ONE OF THE 20 SPANISH HEALTHCARE COMPANIES TO WATCH”
The Barcelona based, women’s fertility startup has developed a molecule, OXO-001, that enhances embryo implantation … [Read more...] about FINANCIAL TIMES: “OXOLIFE IS ONE OF THE 20 SPANISH HEALTHCARE COMPANIES TO WATCH”
lINTERVIEW IN CATALUNYA RADIO. REVOLUCIÓ 4.0
Interview with Agnès Arbat, Oxolife’s CEO and co-founder, presenting the selected startup of the BStartup Health … [Read more...] about lINTERVIEW IN CATALUNYA RADIO. REVOLUCIÓ 4.0
FOUNDING IMPULSE FOR OXOLIFE
The biotechnology company Oxolife returns to its founders: Agnès Arbat and Ignasi Canals have regained the license of … [Read more...] about FOUNDING IMPULSE FOR OXOLIFE